SalaryGuide
AboutPricingFor Employers

Marketing jobs

2 marketing jobs

Danaher logo
4 weeks ago

Senior Global Product Marketing Manager- Hematology

Danaher

Chaska, MN (Remote)Full time$145K/yr – $175K/yr
Danaher logo
6 weeks ago

Regional Marketing Manager - Americas

Danaher

Waltham, MA (Remote)Full time$125K/yr – $140K/yr

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

2 jobs
Danaher logo

Senior Global Product Marketing Manager- Hematology

Danaher

Chaska, MN (Remote)

$145K/yr - $175K/yrIn-houseFull-timeSenior level8+ years exp.
4 weeks ago
Danaher logo

Regional Marketing Manager - Americas

Danaher

Waltham, MA (Remote)

$125K/yr - $140K/yrIn-houseFull-timeMid level7+ years exp.
6 weeks ago
Danaher logo
Danaher

Senior Global Product Marketing Manager- Hematology

Chaska, MN (Remote)

$145K/yr – $175K/yrSenior Level8+ years expFull time

Posted 4 weeks ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own the global hematology marketing strategy and launches, turning clinical workflows and customer pain points into differentiated positioning while coordinating cross functional readiness for multi-market launches.

  • Growth Strategy and Portfolio Positioning: define global hematology strategy, segmentation, and messaging to drive pipeline and conversion.
  • Launch Excellence: lead multi-product launch planning with SMEs across communications, medical, regional, and operations to ensure timely execution.
  • Evidence-based Engagement: partner with Medical Affairs and KOLs to develop thought leadership, podium talks, webinars, and scientific content.

Job Description

Responsibilities
  • Define and execute global marketing strategy for the Hematology portfolio, grounded in deep understanding of clinical hematology workflows, customer pain points, and competitive landscapes to drive differentiated positioning and sustainable growth initiatives.
  • Lead the global launch planning and execution for complex, multi-product hematology launches, independently convening communication, product, medical, regional, and operational SMEs to drive readiness, resolve risks early, and deliver timely execution across markets.
  • Own VOC, market mapping, segmentation, campaign messaging, and lead follow-up strategy across hematology customer segments and geographies, translating customer insights into targeted marketing plans that support pipeline creation and conversion
  • Strengthen global hematology brand awareness and credibility through strategic laboratory medicine tradeshow leadership, congress planning, and scientific storytelling, ensuring consistent brand expression and impactful presence across global and regional events.
  • Develop and activate evidence-based marketing strategies in partnership with Medical and Scientific Affairs, including study planning input, KOL identification, consulting relationships, podium talks, webinars, white papers, and other scientific thought leadership opportunities
Requirements
  • Advanced degree or equivalent experience: Bachelor’s +12 years, Master’s +10 years, or PhD +8 years in life sciences, biotechnology, or related field
  • Industry experience within diagnostics, life sciences, biotechnology, or pharmaceuticals
  • Ability to balance strategic thinking with hands-on execution
  • Proven success leading complex, cross-functional initiatives with measurable outcomes and clear ownership
  • Strong communication and influence skills, with the ability to distill complex scientific data into clear, impactful messaging for diverse audiences including executives
  • Travel, Motor Vehicle Record & Physical/Environment Requirements: - Ability to travel up to 30%, including some international travel
Preferred
  • Sales, Marketing, or Product Management expertise in hematology products.
  • Understanding of laboratory medicine personas and clinical laboratory environment.
  • Experience leading high-performing teams.
Benefits
  • Beckman Coulter Diagnostics offers a comprehensive package of benefits including paid time off, medical/dental/vision insurance and 401(k) to eligible employees.
  • Note: No amount of pay is considered to be wages or compensation until such amount is earned, vested, and determinable. The amount and availability of any bonus, commission, benefits, or any other form of compensation and benefits that are allocable to a particular employee remains in the Company's sole discretion unless and until paid and may be modified at the Company’s sole discretion, consistent with the law.
  • This position is eligible for a remote work arrangement in which you can work remotely from your home. Additional information about this remote work arrangement will be provided by your interview team. Explore the flexibility and challenge that working for Beckman Coulter Diagnostics can provide.

Traffic Signals

Monthly Visitors
313.3K
Traffic Source Mix
Search
29.4%
Direct
36.8%
Referral
23.2%
Social
5.7%
Paid
2.1%

Headcount Trend

Current headcount: ~53.4K

Marketing Team

Marketing Team Size
1,249 (2% of company)
Median Career Experience
13 years
Median Tenure
3.9 years
Marketing Roles Posted (Last 30 Days)
4

People

HR / Recruitment

Alex Desamour
Alex Desamour
Vice President Talent Acquisition
At the company for 4 years 4 months
Steven Zhang
Director, Talent Acquisition-China
At the company for 5 years 9 months

Marketing Leadership

Rachael Cohn
Rachael Cohn
Vice President of Talent Acquisition Operations
At the company for 11 years 3 months
Alex Desamour
Alex Desamour
Vice President Talent Acquisition
At the company for 4 years 4 months
Steven Zhang
Director, Talent Acquisition-China
At the company for 5 years 9 months
Peter Sanborn
Peter Sanborn
Director of Digital Marketing
At the company for 11 years 11 months

Funding

Total Funding
$8B
Last Raise
$3B
Post IPO Debt, 1 months ago

Funding History

  • May 2026
    Post IPO Debt • $3B
  • Apr 2026
    Post IPO Debt • $5B

Recent News

Danaher To Go Ex-Dividend On June 26th, 2026 With 0.4 USD Dividend Per Share
Jun 26, 2026 • Moomoo
Danaher (DHR) Stock Is Up, What You Need To Know
Jun 25, 2026 • Yahoo Finance
Danaher Corp. stock underperforms Thursday when compared to competitors despite daily gains
Jun 25, 2026 • MarketWatch
Danaher (DHR) Stock Weighs Mixed Valuation Signals After Recent Price Rebound
Jun 25, 2026 • Yahoo Finance
Why Danaher (DHR) Stock Rose Today
Jun 25, 2026 • Quiver Quantitative
Danaher (DHR) On FDA Clearance And The Narrative Behind Its Valuation
Jun 25, 2026 • simplywall.st
Eckuity Capital Launches Fund II and Backs Automata Technologies
Jun 25, 2026 • Business Wire
HSBC Cuts PT on Danaher Corporation (DHR) – Here’s Why
Jun 24, 2026 • Insider Monkey
HSBC Cuts PT on Danaher Corporation (DHR) – Here’s Why
Jun 24, 2026 • Yahoo Finance
How FDA Clearance of AI Opioid-Respiratory Monitoring Could Shape Danaher’s (DHR) Clinical Data Advantage
Jun 24, 2026 • simplywall.st
Danaher Is Down 22% This Year. Is the Masimo Acquisition the Entry Point Investors Have Been Waiting for?
Jun 24, 2026 • The Motley Fool
FDA Clears New Masimo Monitoring Feature
Jun 23, 2026 • Orange County Business Journal
Microbiology Testing Market to reach USD 16.41 Billion by 2035 at 9.6% CAGR
Jun 23, 2026 • EIN Presswire
Danaher plans July 21 earnings call, slide deck at 6 a.m. ET
Jun 22, 2026 • Stock Titan
Danaher Finalizes $9.9B Purchase of Masimo
Jun 22, 2026 • Orange County Business Journal
Danaher (DHR) Achieves FDA Clearance for Wearable Monitoring Tec
Jun 22, 2026 • GuruFocus
Danaher's Masimo receives FDA 510k clearance for OIRD detection on Radius VSM
Jun 22, 2026 • legacy.thefly.com
Danaher (DHR) Expands Ebola Testing And AI Drug Filing Push Through Two Subsidiaries
Jun 19, 2026 • simplywall.st
Danaher Corp (DHR) Valuation: PE, PB & Fair Value Analysis
Jun 18, 2026 • TradingKey
Danaher Corp (DHR) Institutional Confidence
Jun 18, 2026 • TradingKey
Danaher Corp. stock outperforms competitors despite losses on the day
Jun 17, 2026 • MarketWatch
Danaher Corp (DHR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
Jun 17, 2026 • TradingKey
Six Takeaways from the Danaher Bioprocessing Summit
Jun 16, 2026 • Genetic Engineering and Biotechnology News
Katie Szyman Steps Down from Masimo
Jun 16, 2026 • Orange County Business Journal
Top six takeaways from the 2026 Danaher Summit on Bioprocessing
Jun 15, 2026 • Danaher Corporation
Danaher’s Cepheid Ebola Tests Highlight Diagnostics Role In Global Crises
Jun 15, 2026 • Yahoo! Finance Canada
Masimo CEO stepping down following acquisition by Danaher
Jun 15, 2026 • Modern Healthcare News
Danaher Corporation’s (DHR) Recovery Fell Short of Investor Expectations
Jun 15, 2026 • Yahoo Finance
Masimo CEO stepping down following acquisition by Danaher
Jun 15, 2026 • Modern Healthcare
Danaher Deepens Diagnostics Reach As Masimo Deal Reshapes Healthcare Focus
Jun 14, 2026 • Yahoo Finance
Danaher Completes Masimo Deal And Broadens Patient Monitoring Growth Story
Jun 12, 2026 • simplywall.st
Danaher boosts product portfolio with the acquisition of Masimo
Jun 12, 2026 • MSN
Danaher Closes Masimo Deal Shifting Monitoring Story Inside Diagnostics Platform
Jun 12, 2026 • simplywall.st
Danaher Boosts Product Portfolio With the Acquisition of Masimo
Jun 12, 2026 • Yahoo Finance
Danaher Corporation $DHR Shares Sold by UniSuper Management Pty Ltd
Jun 12, 2026 • MarketBeat
Danaher Corp. stock underperforms Thursday when compared to competitors
Jun 11, 2026 • MarketWatch
Strong Performance Continues at DHR's Biotechnology Unit: What's Next?
Jun 11, 2026 • Yahoo Finance
Danaher closes $9.9B Masimo buyout
Jun 11, 2026 • MedTech Dive
BofA Securities Maintains Danaher(DHR.US) With Buy Rating, Maintains Target Price $270
Jun 11, 2026 • Moomoo
Danaher Completes Acquisition Of Masimo to Expand Diagnostics Portfolio
Jun 11, 2026 • Pulse 2.0
Is It Time To Reassess Danaher (DHR) After Recent Share Price Recovery?
Jun 11, 2026 • simplywall.st
Piper Sandler Initiates Danaher(DHR.US) With Hold Rating, Announces Target Price $200
Jun 11, 2026 • 富途牛牛
Piper Sandler initiates Danaher stock coverage with neutral rating
Jun 11, 2026 • Investing.com
Danaher Closes $9.9B Acquisition of Masimo
Jun 11, 2026 • Medical Product Outsourcing
Danaher completes acquisition of Masimo, expanding its diagnostics portfolio with advanced patient monitoring tech.
Jun 11, 2026 • Pluang
Danaher Corp. stock underperforms Wednesday when compared to competitors
Jun 10, 2026 • MarketWatch
Danaher completes acquisition of Masimo, company delists from Nasdaq By Investing.com
Jun 10, 2026 • Investing.com Canada
Danaher completes acquisition of Masimo, company delists from Nasdaq
Jun 10, 2026 • Investing.com
Danaher acquires Masimo to bolster diagnostics capabilities
Jun 10, 2026 • grafa.com
Danaher Closes Acquisition of Masimo; Maintains Q2, 2026 Outlook
Jun 10, 2026 • marketscreener.com
Danaher acquires Masimo (MASI) in all-cash $180-per-share takeover and delisting
Jun 10, 2026 • Stock Titan
Danaher Corporation Completes Acquisition of Masimo Corporation on June 10, 2026
Jun 10, 2026 • geneonline.com
Danaher completes acquisition of Masimo Corporation
Jun 10, 2026 • Investing.com
Danaher completes acquisition of Masimo Corporation
Jun 10, 2026 • Investing.com India
Danaher Completes Acquisition of Masimo, Expanding Acute Care Diagnostics Platform
Jun 10, 2026 • citybiz
Danaher buys Masimo, adding AI patient-monitoring tech in acute care
Jun 10, 2026 • Stock Titan
Danaher completes $10B acquisition of Masimo
Jun 10, 2026 • MassDevice
Danaher (DHR) Completes Acquisition of Masimo, Expanding Diagnos
Jun 10, 2026 • GuruFocus
Danaher Completes Acquisition of Masimo Corporation
Jun 10, 2026 • Yahoo Finance
Danaher Corporation completed the acquisition of Masimo Corporation from a group of shareholders.
Jun 10, 2026 • MarketScreener
Danaher Completes Acquisition of Masimo Corporation
Jun 10, 2026 • PR Newswire
Masimo Corporation Announces Board and Committee Changes
Jun 10, 2026 • MarketScreener
Danaher Closes on Acquisition of Masimo
Jun 10, 2026 • Orange County Business Journal
Wolfe Research Downgrades Danaher Corporation (DHR)
Jun 9, 2026 • Yahoo Finance
Wolfe Research Downgrades Danaher Corporation (DHR)
Jun 9, 2026 • Insider Monkey
Danaher (DHR) Moves Towards Acquisition of Masimo (MASI)
Jun 8, 2026 • GuruFocus
Danaher (DHR) Has a Recovery-and-Execution Story That Looks Better Than a Plain Lab-Spending Trade
Jun 8, 2026 • AlphaStreet
Danaher (DHR) Moves Towards Acquisition of Masimo (MASI)
Jun 8, 2026 • GuruFocus
High Throughput Screening Market to reach USD 70.18 Billion by 2035 at 10.42% CAGR
Jun 8, 2026 • EIN Presswire
Sirius XM Holdings Set to Join S&P MidCap 400
Jun 8, 2026 • Morningstar.com
Why Wall Street Sees Danaher (DHR) Benefiting From Improving Industry Conditions
Jun 7, 2026 • Yahoo Finance
Danaher Insiders Sold US$235m Of Shares Suggesting Hesitancy
Jun 6, 2026 • Yahoo Finance
Danaher Corp. stock outperforms competitors despite losses on the day
Jun 5, 2026 • MarketWatch
Reassessing Danaher (DHR) Valuation After Mixed Share Performance And Conflicting Undervaluation Signals
Jun 5, 2026 • simplywall.st
Danaher’s vision for smarter infectious disease testing - SelectScience interview
Jun 4, 2026 • Select Science
Danaher jumps as investors focus on fresh financing steps and Masimo deal progress | DHR Stock News
Jun 4, 2026 • Quiver Quantitative
Danaher (DHR) Initiated with a Buy at DZ BANK AG
Jun 4, 2026 • The Globe and Mail
Danaher Corp. stock outperforms competitors on strong trading day
Jun 4, 2026 • MarketWatch
HSBC Adjusts Price Target on Danaher to $230 From $270, Maintains Buy Rating
Jun 3, 2026 • Moomoo
Leica Biosystems Announces Expansion of Collaboration to Scale Precision Medicine and Develop AI-Powered Diagnostics
Jun 3, 2026 • Yahoo Finance
What Danaher (DHR)'s New AI-Enabled SCIEX Mass Spec Platform Means For Shareholders
Jun 2, 2026 • simplywall.st
Baron Durable Advantage Fund Exits Danaher, CoStar Positions Amid Portfolio Repositioning
May 28, 2026 • citybiz
Danaher Corp. stock (US2358511028): dividend timeline and institutional interest in focus
May 26, 2026 • AD HOC NEWS
Masimo earnings in focus as Danaher deal nears close
May 24, 2026 • Investing.com
Research Tools & Consumables Stocks Q1 Results: Benchmarking Danaher (NYSE:DHR)
May 23, 2026 • Yahoo Finance
Danaher Corp. stock (US2358511028): earnings beat keeps focus on life sciences recovery
May 22, 2026 • AD HOC NEWS
Danaher Targets Carbon Capture And AI CMC To Shape Long Term Growth
May 22, 2026 • Yahoo Finance
Danaher raises $3 billion in record private-placement bond sale - Bloomberg News
May 22, 2026 • TradingView
Danaher Raises $3 Billion in Record Private-Placement Bond Sale
May 22, 2026 • Bloomberg.com
Danaher stock (US2358511028): spin-off, diagnostics focus and what the latest numbers reveal
May 21, 2026 • AD HOC NEWS
Danaher Corp. stock outperforms competitors on strong trading day
May 20, 2026 • MarketWatch
Danaher to Present at Bank of America Securities Healthcare Conference
May 6, 2026 • PR Newswire
Masimo Shareholders Approve Acquisition by Danaher
May 4, 2026 • Business Wire
Masimo Shareholders Approve $9.9B Sale to Danaher
May 4, 2026 • Orange County Business Journal
Masimo shareholders approve acquisition by Danaher
May 4, 2026 • legacy.thefly.com
COVID-19 Detection Test Kits and Consumables Market Analysis Report 2026: $13.23 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
Apr 30, 2026 • GlobeNewswire
Why Medtech Giants Are Quietly Paying Up for AI Diagnostics
Apr 29, 2026 • PR Newswire
Why Medtech Giants Are Quietly Paying Up for AI Diagnostics
Apr 29, 2026 • Canada NewsWire
Danaher Corporation (DHR) Reports Q1 Adjusted EPS Beat
Apr 25, 2026 • Yahoo Finance
This Stock Is Up Over 52,700% Since Founding. Should Investors Buy After Its 36% Decline?
Apr 24, 2026 • The Motley Fool